NimBio is developing a noninvasive inflammometer and flarometer for use in treating chronic immune-mediated inflammatory diseases.

The early detection of flare-ups on the individual patient level is based on a set of selected parameters at the subclinical stage.NimBio’s breakthrough flare-prevention technology uses noninvasive predictive tools via wearable technology and has shown tremendous promise in a proof-of-concept clinical study.